共 50 条
- [1] Plasticity in muscle-invasive bladder cancer before and after cisplatin-based neoadjuvant chemotherapy[J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 618 - 618Seiler, RolandGibb, Ewan A.Takhar, MandeepVan Kessel, Kimvan Rhijn, Bas W. G.Winters, BrianDouglas, JamesWang, QiqiChoeurng, VoleakErho, NicholasBuerki, ChristineDavicioni, ElaiSjodahl, GottfridThalmann, George N.Zwarthoff, Ellen C.Boormans, Joost L.Dall'Era, Marcvan der Heijden, Michiel S.Wright, JonathanBlack, Peter C.
- [2] Downstaging and Survival Associated with Neoadjuvant Immunotherapy Before Radical Cystectomy for Muscle-invasive Bladder Cancer[J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (01): : 139 - 146Grassauer, JacobSchmidt, JacksonCowan, AndrewGilbert, Scott M.Chakiryan, Nicholas H.
- [3] Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer[J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 614 - 624Li, RogerNocera, LuigiRose, Kyle M.Raggi, DanieleNaidu, ShreyasMercinelli, ChiaraCigliola, AntonioTateo, ValentinaPatane, DamianoGrass, G. DanielGilbert, Scott M.Sexton, Wade J.Bandini, MarcoMoschini, MarcoBriganti, AlbertoMontorsi, FrancescoSpiess, Philippe E.Necchi, Andrea
- [4] Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer[J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) : 1172 - 1177Stevenson, Scott M.Danzig, Matthew R.Ghandour, Rashed A.Deibert, Christopher M.Decastro, G. JoelBenson, Mitchell C.McKiernan, James M.
- [5] Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer[J]. PLOS ONE, 2016, 11 (05):Guancial, Elizabeth A.Kilari, DeepakXiao, Guang-QianAbu-Farsakh, Sohaib H.Baran, AndreaMessing, Edward M.Kim, Eric S.
- [6] The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy[J]. International Journal of Clinical Oncology, 2017, 22 : 159 - 165Hiromi MurasawaTakuya KoieChikara OhyamaHayato YamamotoAtsushi ImaiShingo HatakeyamaTakahiro YoneyamaYasuhiro HashimotoIkuya IwabuchiMasaru OgasawaraToshiaki Kawaguchi
- [7] The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy[J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (01) : 159 - 165Murasawa, HiromiKoie, TakuyaOhyama, ChikaraYamamoto, HayatoImai, AtsushiHatakeyama, ShingoYoneyama, TakahiroHashimoto, YasuhiroIwabuchi, IkuyaOgasawara, MasaruKawaguchi, Toshiaki
- [8] Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer[J]. CANCER, 2012, 118 (01) : 44 - 53Alva, Ajjai S.Tallman, Christopher T.He, ChangHussain, Maha H.Hafez, KhaledMontie, James E.Smith, David C.Weizer, Alon Z.Wood, DavidLee, Cheryl T.
- [9] NEOADJUVANT CHEMOTHERAPY PRIOR TO RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER WITH VARIANT HISTOLOGY[J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E431 - E431Vetterlein, Malte W.Mullane, StephanieSeisen, ThomasLander, RichardLoppenberg, BjornChoueiri, Toni K.Bellmunt, JoaquimMenon, ManiKibel, Adam S.Quoc-Dien TrinhPreston, Mark A.
- [10] Neoadjuvant Chemotherapy Prior to Radical Cystectomy for Muscle-Invasive Bladder Cancer With Variant Histology[J]. CANCER, 2017, 123 (22) : 4346 - 4355Vetterlein, Malte W.Wankowicz, Stephanie A. M.Seisen, ThomasLander, RichardLoppenberg, BjornChun, Felix K. -H.Menon, ManiSun, MaxineBarletta, Justine A.Choueiri, Toni K.Bellmunt, JoaquimQuoc-Dien TrinhPreston, Mark A.